Skip to content

Ovarian Cancer Research Grant Programs

Grant Programs

OCRA’s Schreiber Research Grants Program supports gifted scientists at every stage of their careers, including postdoctoral fellows, early-career independent investigators, and teams of experienced investigators.

Championing the Most Promising Research

OCRA has awarded over 350 grants to top scientists at more than 90 leading medical centers around the world. With an annual budget of over $7 million, our grants have enabled a series of discoveries that have accelerated our journey toward a cure. All of our grants involve a rigorous review process to ensure that only the most outstanding research projects are funded.

  • Collaborative Research Development Grant

    Launched in 2004, this grant provides funds for research projects that involve several investigators within one institution or collaborations between groups in multiple institutions. Support of $300,000 annually for three years, for a total of $900,000, will be awarded to the institution(s) where the recipients will conduct the research.

  • Collaborative Research Development Grant – Microsoft AI for Health

    Launched in 2022, this grant is the result of a unique partnership between OCRA and Microsoft AI for Health, a philanthropic program at Microsoft. This collaboration will help OCRA accelerate ovarian cancer research by harnessing the power of data science and Artificial Intelligence (AI), potentially leading to new insights into the disease. The grant will provide funds for ovarian cancer and/or related gynecologic cancers research projects that may involve several investigators within one institution or collaborations between groups in multiple institutions. Support of $300,000 annually for three years, for a total of $900,000, will be awarded to the institution(s) where the recipients will conduct the research in addition to in-kind support from Microsoft.

  • Early Career Investigator Grant

    The Early Career Investigator Grant (formerly the Liz Tilberis Early Career Award) is for junior faculty (Assistant Professor level) with a strong commitment to an investigative career in ovarian cancer or related gynecologic cancer research. Each grantee will receive a three-year grant of $150,000 per year, for a total of $450,000.

  • Mentored Investigator Grant

    The Mentored Investigator Grant (formerly the Ann and Sol Schreiber Mentored Investigator Award) provides funding for trainees (post-doctoral fellows or clinical fellows) working under the supervision of a mentor who is a recognized leader in ovarian cancer research. Applicants must have an MD or a PhD degree. The grant provides a total of $100,000 to be used over one or two years and will encourage the recipient’s research career in the field of ovarian cancer and related gynecologic cancers.

  • Health Equity Research Grant

    OCRA’s first-ever Health Equity Research Grant (HEG) was launched in 2024. The first grant was sponsored by GSK. This grant is intended to overcome barriers to care faced by marginalized communities and is geared to all investigators with projects focusing on ovarian cancer and/or related gynecologic cancers research that have a health equity focus. Support of $100,000 annually for two years, for a total of $200,000, will be awarded to the institution where the recipient will conduct the research.

Related Topics

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.